SE419222B - Forfarande for framstellning av derivat av oxatiino (1,4)(2,3-c) pyrrol - Google Patents

Forfarande for framstellning av derivat av oxatiino (1,4)(2,3-c) pyrrol

Info

Publication number
SE419222B
SE419222B SE7512476A SE7512476A SE419222B SE 419222 B SE419222 B SE 419222B SE 7512476 A SE7512476 A SE 7512476A SE 7512476 A SE7512476 A SE 7512476A SE 419222 B SE419222 B SE 419222B
Authority
SE
Sweden
Prior art keywords
oxatiino
pyrrol
derivative
preparing
procedure
Prior art date
Application number
SE7512476A
Other languages
English (en)
Other versions
SE7512476L (sv
Inventor
M Barreau
C Cotrel
C Jeanmart
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of SE7512476L publication Critical patent/SE7512476L/sv
Publication of SE419222B publication Critical patent/SE419222B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D497/00Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
SE7512476A 1974-11-07 1975-11-06 Forfarande for framstellning av derivat av oxatiino (1,4)(2,3-c) pyrrol SE419222B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7436962A FR2290208A1 (fr) 1974-11-07 1974-11-07 Nouveaux derives de l'oxathiinno(1,4)(2,3-c)pyrrole, leur preparation et les compositions qui les contiennent

Publications (2)

Publication Number Publication Date
SE7512476L SE7512476L (sv) 1976-05-10
SE419222B true SE419222B (sv) 1981-07-20

Family

ID=9144747

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7512476A SE419222B (sv) 1974-11-07 1975-11-06 Forfarande for framstellning av derivat av oxatiino (1,4)(2,3-c) pyrrol

Country Status (28)

Country Link
US (1) US4021554A (sv)
JP (2) JPS6029716B2 (sv)
AR (2) AR214045A1 (sv)
AT (1) AT342603B (sv)
AU (1) AU503381B2 (sv)
BE (1) BE835324A (sv)
CA (1) CA1054599A (sv)
CH (2) CH608808A5 (sv)
CS (1) CS191285B2 (sv)
DD (1) DD122541A5 (sv)
DE (1) DE2550163C2 (sv)
DK (1) DK499175A (sv)
ES (2) ES442441A1 (sv)
FI (1) FI59251C (sv)
FR (1) FR2290208A1 (sv)
GB (1) GB1466829A (sv)
HU (1) HU170500B (sv)
IE (1) IE42030B1 (sv)
IL (1) IL48422A (sv)
LU (1) LU73737A1 (sv)
NL (1) NL7512731A (sv)
NO (1) NO143534C (sv)
OA (1) OA05141A (sv)
PH (1) PH14755A (sv)
SE (1) SE419222B (sv)
SU (2) SU576949A3 (sv)
YU (2) YU281175A (sv)
ZA (1) ZA756953B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1072557A (fr) * 1976-02-20 1980-02-26 Rhone-Poulenc Industries Derives du dithiepinno (1,4)(2,3-c) pyrrole, leur preparation et les compositions qui les contiennent
FR2525605A1 (fr) * 1982-04-22 1983-10-28 Rhone Poulenc Sante Nouveaux derives du dithiinno (1,4) (2,3-c) pyrrole, leur preparation et les medicaments qui les contiennent
FR2607504B1 (fr) * 1986-12-02 1989-01-27 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
AU2008255565B2 (en) * 2007-05-31 2013-10-24 Paradigm Biopharmaceuticals Ltd Sulphated xylans for treatment or prophylaxis of respiratory diseases

Also Published As

Publication number Publication date
LU73737A1 (sv) 1976-09-06
CS191285B2 (en) 1979-06-29
IL48422A0 (en) 1976-01-30
DE2550163C2 (de) 1984-11-22
DK499175A (da) 1976-05-08
NO753712L (sv) 1976-05-10
AU503381B2 (en) 1979-08-30
ES442442A1 (es) 1977-07-01
ATA848575A (de) 1977-08-15
SU615860A3 (ru) 1978-07-15
FI59251B (fi) 1981-03-31
IE42030L (en) 1976-05-07
JPS60222484A (ja) 1985-11-07
NO143534C (no) 1981-03-04
HU170500B (sv) 1977-06-28
AR214045A1 (es) 1979-04-30
US4021554A (en) 1977-05-03
IE42030B1 (en) 1980-05-21
IL48422A (en) 1979-03-12
ZA756953B (en) 1976-10-27
CH608808A5 (sv) 1979-01-31
FI59251C (fi) 1981-07-10
JPS5170792A (en) 1976-06-18
YU281175A (en) 1982-08-31
AT342603B (de) 1978-04-10
YU108082A (en) 1982-08-31
SE7512476L (sv) 1976-05-10
ES442441A1 (es) 1977-04-01
CH608238A5 (sv) 1978-12-29
PH14755A (en) 1981-11-20
GB1466829A (en) 1977-03-09
OA05141A (fr) 1981-01-31
SU576949A3 (ru) 1977-10-15
JPS6111954B2 (sv) 1986-04-05
BE835324A (fr) 1976-05-06
JPS6029716B2 (ja) 1985-07-12
NL7512731A (nl) 1976-05-11
FI753126A (sv) 1976-05-08
AR214400A1 (es) 1979-06-15
FR2290208B1 (sv) 1978-07-28
NO143534B (no) 1980-11-24
FR2290208A1 (fr) 1976-06-04
DD122541A5 (sv) 1976-10-12
AU8633275A (en) 1977-05-12
CA1054599A (fr) 1979-05-15
DE2550163A1 (de) 1976-05-20

Similar Documents

Publication Publication Date Title
SE434049B (sv) Forfarande for framstellning av 1,4-dihydropyridinderivat
SE421698B (sv) Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno (2,3-c) pyridinderivat
SE416203B (sv) Forfarande for framstellning av 4,5,6,7-tetrahydro-furo (respektive - tieno)-(3,2-c)pyridinderivat
SE429970B (sv) Forfarande for framstellning av glukopyranosido-1,6-mannit
SE421623B (sv) Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno(2,3-c respektive 3,2-c)-pyridinderivat
NO145433C (no) Fremgangsmaate til fremstilling av 1,3-butadien.
SE7808059L (sv) Forfarande for framstellning av 1,2,4-triazin-5-on-derivat
SE421795B (sv) Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno(3,2-c)pyridin-derivat
SE422065B (sv) Forfarande for framstellning av nya derivat av tiazolo-(3,4-b)-isokinolin
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE416650B (sv) Forfarande for framstellning av 3-fenylsubstituerade-6-hydrazinpyridazin derivat
SE7508074L (sv) Forfarande for framstellning av stilbenderivat.
DK134551C (da) Fremgangsmade til fremstilling af 1,2,4-triazolderivater
SE439631B (sv) Forfarande for framstellning av 3,4-dihydrokarbostyrilderivat
SE428017B (sv) Forfarande for framstellning av 2,6 - metano - 2h-l- bensoxocinderivat
SE395150B (sv) Forfarande for framstellning av derivat av pyrazol(3,4-b)pyridinketoner
SE422579B (sv) Forfarande for framstellning av 4-oxo-hexahydro-pyrazino(2,1-a)isokinolinderivat
SE421622B (sv) Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno(3,2-c)-pyridinderivat
NO142786C (no) Fremgangsmaate til fremstilling av diosmin.
SE419222B (sv) Forfarande for framstellning av derivat av oxatiino (1,4)(2,3-c) pyrrol
SE425248B (sv) Forfarande for framstellning ac derivat av 4-tia-2,6-diaza(3.2.0)-2-hepten-oner
SE424638B (sv) Analogiforfarande for framstellning av 5,7-dihydroxi-tetrahydroisokinolin derivat
SE421529B (sv) Forfarande for framstellning av tieno(3,2-c)pyridin-derivat
SE421700B (sv) Forfarande for framstellning av 2-alkoxikarbonyl-4,5,6,7-tetrahydrotieno(3,2-c)pyridinderivat
SE432251B (sv) Forfarande for framstellning av dibenso(b,d)pyraner